Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
Titel:
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
Auteur:
Nizam, Amanda Rader, Ryan K. Tzeng, Alice Wei, Wei Sheng, Iris Yeong-Fung Martin, Allison Wee, Christopher E. Gilligan, Timothy D. Gupta, Shilpa Ornstein, Moshe C.